Back to all database documentation: Neurofibromatosis Research Tools Database: Documentation
Antibodies:
must pass schematic validation
epitope should be formatted using the following style:
if phospho-specific, have the prefix “phospho-” followed by
gene symbol/protein symbol e.g. “NF2” followed by
if phospho-specific, should label the phospho-target in parentheses with the three-character amino acid (aa) abbreviation followed by the location e.g. “(Ser2515)” followed by
if mutation-specific, should label the protein variant using one-character aa abbreviation eg. “(G12V)” followed by
if available, aa location of target in parentheses in the format of (aa START-END) e.g. “(aa 100-150)” or “(aa 507-530 N-term)”
examples of valid epitopes:
NF1
phospho-NF1 (Ser2515)
KRAS (G12V)
NF1 (aa 100-150)
NF1 (aa 507-530 N-term)
...